-+ 0.00%
-+ 0.00%
-+ 0.00%

Neurogene files initial beneficial ownership statement for Chief Commercial Officer Christina Shafer

PUBT·04/20/2026 22:27:18
Listen to the news
Neurogene files initial beneficial ownership statement for Chief Commercial Officer Christina Shafer
  • Neurogene filed an initial Form 3 naming Christina Shafer as chief commercial officer on April 20, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001934412-26-000004), on April 20, 2026, and is solely responsible for the information contained therein.